Tracevskis, Rokas M.
Koolide remondiprojektiga seoses nõudis Leedu president Dalia Grybauskate majandusminister Dainius Kreivyse tagasiastumist, kuna projekti pidi teostama ettevõte, mille osanikuks on ka majandusministri ema. 8. märtsil teatas Dainius Kreivys oma tagasiastumisest
Tracevskis, Rokas M.
15. veebruaril teatas Leedu president Dalia Grybauskaite, et seoses koolide remondiprojektiga ei usalda ta majandusminister Dainius Kreivyst. 21. veebruaril toimunud peaminister Andrius Kubiliuse ja majandusminister Dainius Kreivyse kohtumisel otsustati, et Kreivys jätkab majandusministrina. President oli koheselt teatanud, et nõuab viimase tagasiastumist
Hausi galeriis Rein Raua kureeritud rahvusvaheline kunstinäitus "KevadSuviSügisTalv. Murdumispunkt". Esinevad Eve Kask, Peeter Laurits, Dainius Lickevicius, Rehka Menon, Mall Nukke, Herkki Merila, Jorma Puranen, Rosita Raud, Ene-Liis Semper, Liina Siib, S. ja P. Stanikas
21. dets.-12. jaan. on on Haus galeriis Rein Raua kuraatoriprojekt "KevadSuviSügisTalv. Murdumispunkt". Näitusel osalevad Eve Kask, Peeter Laurits, Dainius Lishkevicius (Leedu), Rekha Menon (India/USA), Mall Nukke, Herkki Merila, Jorma Puranen (Soome), Rosita Raud, Ene-Liis Semper, Liina Siib, S&P Stanikas (Leedu)
Baltimaade juhtivate õlletootjate marketingijuhid Martins Dzenis (Cesu Alus), Inita Drezina (Aldaris), Eriks Kalita (Livu Alus), Raimonds Kalnins (Kimmel), Dalius Rutkauskas (AB Ragutis), Dainius Smailys (Svyturis-Utenos Alus), Katrin Vernik (A. Le Coq Eesti), Karin Sepp (Saku Õlletehas) ja Härmo Põlluvee (Frederik Viru Õlu) olukorrast Baltimaade õlleturul, suurematest tarbijamängudest ja reklaamikampaaniatest. Tabelid
Komissarov, Eha, 1947-
Leedu kaasaegse kunsti näitus "Omas mahlas" Tallinna Kunstihoones (Evaldas Jansas, Egle Rakauskaite) ja Rotermanni soolalaos (Loreta Bilinskaite-Burke, Laura Barbshtiene & Arturas Bumshteinas (G-Lab), Jonas Gasiunas, Arunas Gudaitis, Linas Jablonskis, Dainius Lishkevicius, Mindaugas Lukoshaitis, Gintaras Makarevicius, Deimantas Narkevicius, Egle Ridikaite, Irma Stanaityte, Laura Stasiulyte, Mindaugas Shimkus, Arturas Valiauga, Rimaldas Vikshraitis, Darius Zhiura). Kuraator Anders Kreuger leedu kunstniku kuvandiloomest
Meier, Benjamin Mason
Before the 2017 election of the Director-General of WHO, and given the importance of human rights to global health governance through WHO, Health and Human Rights asked the three final candidates for their views on human rights, WHO's human rights mandate, and the role of human rights in WHO programming. These questions were developed by the author in collaboration with Audrey Chapman, Lisa Forman, Paul Hunt, Dainius Pūras, Javier Vasquez and Carmel Williams. Based on responses to these questions from each of the three candidates, this Perspective was originally published online on April 26, 2017. On May 23, 2017, Dr Tedros Adhanom Ghebreyesus was elected Director-General and will begin his five-year term on July 1, 2017.
Kazlauskaite-Jadzevice, Asta; Marcinkonis, Saulius; Baksiene, Eugenija
Soil renaturalization or ecological recovery has been studied from local to global scales. On a global scale - it's one of the ways of carbon fixation, preservation of natural diversity, locally - renaturalization processes help to solve problems of damaged (eroded and polluted) and infertile soils areas. Efficient land use can improve soil structure and therefore be attractive as a renewable energy resource that can encourage thermal energy, fuel production and installation of new technologies. Soil renaturalization is very important not only in that it helps to decrease the impact on the environment, but it can produce higher energy value of biomass at a lower cost. The aim of this study is to evaluate and compare different renaturalization methods through analyzing biomass yields and chemical composition (pine afforested, fallowing, manage grassland - Alfalfa and cropland) carried out during almost two decades (1995 - 2012). The four stationary experimental sites were set up in 1995 in Vilnius district, Lithuania. Common sandy soils prevail in the region, and the agronomic value of soil is very low. All sites were arranged in one row (the divided sides is 400 m2 each). Managed grassland and cropland areas were subdivided into fertilized and unfertilized subplots. The size of the subdivided plots was 200 m2 each. Gross productions (straw, grain, hay, pine biomass) was recalculated into total energy amount (in the calculationswere used K. Neringa and R. Siman equation) expressed in MJ and the site's productivity data compared. Gross productions total energy amount of pine afforestration was recalculated into trees volume using diameter (DBH), height and density of pines. Observed data suggest that the difference between fertilized and unfertilized plots in the cropland site was on average 1.62 times and made up an average of 20 339 MJ y-1 ha-1. The grassland site was characterized by higher productivity and a bigger difference of total energy between fertilized
Full Text Available Michael J Davies,1 Katherine W Merton,1 Ujjwala Vijapurkar,2 Dainius A Balis,2 Mehul Desai2 1Janssen Scientific Affairs, LLC, Titusville, NJ, USA; 2Janssen Research & Development, LLC, Raritan, NJ, USA Objective: Metabolic syndrome refers to a collection of risk factors associated with the development of cardiovascular disease and type 2 diabetes mellitus (T2DM. Canagliflozin, a sodium glucose co-transporter 2 inhibitor, improves glycemic control and reduces body weight and blood pressure (BP in a broad range of patients with T2DM. This post hoc analysis assessed the effects of canagliflozin on the components of metabolic syndrome in patients with T2DM and metabolic syndrome.Methods: This analysis was based on data from 2 head-to-head studies of canagliflozin in patients with T2DM on background metformin versus glimepiride (study 1 and background metformin plus sulfonylurea versus sitagliptin 100 mg (study 2. Changes from baseline in glycemic efficacy, anthropometric measures, BP, and lipids were evaluated with canagliflozin versus glimepiride and sitagliptin at week 52 in patients who met ≥2 of the criteria for metabolic syndrome (in addition to T2DM: triglycerides ≥1.7 mmol/L; high-density lipoprotein cholesterol (HDL-C <1.0 mmol/L (men or <1.3 mmol/L (women; waist circumference ≥102 cm (non-Asian men, ≥88 cm (non-Asian women, >90 cm (Asian men, or >80 cm (Asian women; diagnosis of hypertension or meeting BP-related criteria (systolic BP ≥130 mmHg or diastolic BP ≥85 mmHg. Safety was assessed based on adverse event reports.Results: In study 1, canagliflozin 100 and 300 mg provided similar and greater HbA1c reductions versus glimepiride, respectively. In study 2, canagliflozin 300 mg provided greater HbA1c lowering versus sitagliptin 100 mg. Canagliflozin also reduced fasting plasma glucose, body weight, body mass index, waist circumference, BP, and triglycerides, and increased HDL-C and low-density lipoprotein cholesterol versus